Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001161697-12-000410)

Filing Details

Accession Number:: 0001161697-12-000410
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-05-29 19:02:37
Reporting Period:: 2012-05-24

Filing Date:: 2012-05-29
Accepted Time:: 2012-05-29 18:02:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1369568	Catalyst Pharmaceutical Partners Inc.	CPRX	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
929985	J Patrick Mcenany	355 Alhambra Circle, Suite 1500 Coral Gables FL 33134	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	Acquisiton	2012-05-24	31,250	$0.80	3,208,797	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrants to Purchase Common Stock	Acquisiton	2012-05-24	31,250	$0.00	31,250	$1.04

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
1,009,191	2012-05-30	2017-05-30	No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, Par Value $0.001 Per Share	145,922	Indirect	.

Footnotes

Securities were sold as units, each consisting of one share of the Issuer's common stock and one five-year warrant to purchase one share of the Issuer's common stock, at a price of $0.80 per unit.
Shares are owned by the Reporting Person's spouse.